Free Trial

Bio-Rad Laboratories (BIO) Competitors

Bio-Rad Laboratories logo
$296.87 +3.20 (+1.09%)
As of 03:22 PM Eastern

BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs. Its Competitors

Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

Mettler-Toledo International has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Mettler-Toledo International has a net margin of 21.46% compared to Bio-Rad Laboratories' net margin of 12.50%. Bio-Rad Laboratories' return on equity of 4.01% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mettler-Toledo International21.46% -476.07% 26.05%
Bio-Rad Laboratories 12.50%4.01%2.82%

Mettler-Toledo International currently has a consensus target price of $1,311.11, indicating a potential upside of 1.33%. Bio-Rad Laboratories has a consensus target price of $333.50, indicating a potential upside of 12.32%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Bio-Rad Laboratories
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, Mettler-Toledo International had 11 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 21 mentions for Mettler-Toledo International and 10 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.38 beat Bio-Rad Laboratories' score of 1.21 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mettler-Toledo International
19 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bio-Rad Laboratories
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.87B6.88$863.14M$39.4932.77
Bio-Rad Laboratories$2.57B3.13-$1.84B$11.7325.31

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$8.03B$10.74B$5.76B$21.24B
Dividend YieldN/A1.87%3.95%3.51%
P/E Ratio25.3121.7531.4529.25
Price / Sales3.1328.43431.0468.26
Price / Cash28.1824.7837.7523.86
Price / Book1.133.4910.535.35
Net Income-$1.84B$211.94M$3.28B$996.52M
7 Day Performance-2.01%1.35%0.37%0.25%
1 Month Performance17.68%13.50%5.15%3.32%
1 Year Performance-11.03%-7.25%50.24%11.89%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO
Bio-Rad Laboratories
4.507 of 5 stars
$296.87
+1.1%
$333.50
+12.3%
-10.6%$8.03B$2.57B25.317,700Positive News
Analyst Upgrade
MTD
Mettler-Toledo International
4.072 of 5 stars
$1,315.45
+0.2%
$1,288.89
-2.0%
-9.8%$27.03B$3.87B33.3117,300Positive News
WAT
Waters
4.7778 of 5 stars
$289.15
-0.8%
$378.73
+31.0%
-12.8%$17.35B$2.96B26.077,600Trending News
ILMN
Illumina
4.6928 of 5 stars
$100.53
+0.4%
$124.58
+23.9%
-24.7%$15.39B$4.37B12.739,030Positive News
TECH
Bio-Techne
4.9658 of 5 stars
$53.29
-0.6%
$69.42
+30.3%
-24.1%$8.40B$1.22B115.853,100Positive News
CRL
Charles River Laboratories International
4.1015 of 5 stars
$157.27
+0.4%
$175.69
+11.7%
-17.3%$7.71B$4.05B-118.2520,100Positive News
BRKR
Bruker
4.9666 of 5 stars
$34.24
+2.1%
$51.30
+49.8%
-48.1%$5.09B$3.37B65.8511,396Positive News
Analyst Revision
PACB
Pacific Biosciences of California
2.1042 of 5 stars
$1.33
+1.5%
$1.90
+42.9%
-1.5%$393.49M$154.01M-0.58730Positive News
HBIO
Harvard Bioscience
3.7665 of 5 stars
$0.50
-4.6%
$3.00
+494.4%
-82.5%$23.56M$94.14M-0.39490
TMO
Thermo Fisher Scientific
4.948 of 5 stars
$488.15
-0.2%
$593.00
+21.5%
-20.0%$184.66B$42.88B28.23125,000Positive News
Insider Trade
A
Agilent Technologies
4.7027 of 5 stars
$118.44
-0.6%
$139.77
+18.0%
-11.3%$33.86B$6.51B29.2417,900Trending News
Earnings Report
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:BIO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners